Summary of Key Information:
Reporting Period (Quarter/Year): Quarter ended June 30, 2026 (Q1 FY27)
Nature of Filing / Announcement: Outcome of Board Meeting and Unaudited Financial Results
Date of Board Meeting / Approval: August 5, 2026 (commenced at 7:30 P.M., concluded at 10:00 P.M.)
Audit Opinion: Limited Review Report - No modifications. However, auditors relied on reports from other auditors for subsidiaries.
Auditor’s Comment: The review report states that nothing has come to their attention to believe the statements contain any material misstatement. A significant qualification is that they did not review the interim financial results of four foreign subsidiaries and one Indian subsidiary, whose combined net profit (before consolidation adjustments) was ₹164.89 lakhs. Their conclusion for these entities is based solely on the reports of other auditors and management's conversion adjustments.
Key Financial Highlights [Amount in INR Lakhs]
Consolidated Results:
Revenue from Operations: ₹5,578.77 (QoQ: decreased from ₹5,641.03 in Q4 FY26; YoY: increased from ₹5,332.36 in Q1 FY26)
Total Income: ₹5,599.25
Net Profit (Loss): (₹1,931.96) (QoQ: deteriorated from a profit of ₹5,288.48 in Q4 FY26; YoY: deteriorated from a loss of ₹1,601.68 in Q1 FY26)
EPS: Not annualized, negative.
Total Comprehensive Income: (₹1,865.48)
Standalone Results:
Revenue from Operations: ₹5,416.81 (QoQ: decreased from ₹5,621.06 in Q4 FY26; YoY: increased from ₹5,231.24 in Q1 FY26)
Total Income: ₹5,435.11
Net Profit (Loss): (₹2,127.40) (QoQ: deteriorated from a profit of ₹5,241.13 in Q4 FY26; YoY: deteriorated from a loss of ₹1,664.40 in Q1 FY26)
EPS: (₹4.16)
Total Comprehensive Income: (₹2,003.32)
Segment-wise Performance [Amount in INR Lakhs]:
Consolidated Segment Revenue (Q1 FY27):
- Sugar: ₹25,341.27
- Cogeneration: ₹2,448.54
- Bio based Chemicals: ₹16,867.10
- Distillery: ₹15,548.35
- Interunit Transfer: (₹5,543.46)
- Unallocated: ₹1,125.90
Consolidated Segment Result - Operating Profit/(Loss) Before Interest & Exceptional Items (Q1 FY27):
- Sugar: (₹1,603.97)
- Cogeneration: (₹797.62)
- Bio based Chemicals: ₹1,583.30
- Distillery: (₹177.38)
- Unallocated: (₹195.94)
Total: (₹1,191.61)
Standalone Segment Result - Operating Profit/(Loss) Before Interest & Exceptional Items (Q1 FY27):
- Sugar: (₹1,682.35)
- Cogeneration: (₹797.62)
- Bio based Chemicals: ₹1,400.65
- Distillery: (₹177.38)
- Unallocated: (₹195.26)
Total: (₹1,442.96)
Corporate Actions:
- The Board approved the Notice convening the 71st Annual General Meeting (AGM) of the Company to be held on Monday, September 28, 2026, through Video Conference (VC). No dividend was declared.
Other Significant Information:
Entities included in consolidation:
- Subsidiaries: Solar Magic Private Limited, Cayuga Investments B.V, Godavari Biorefineries B.V (Subsidiary of Cayuga Investments B.V), Godavari Biorefineries Inc. (Subsidiary of Cayuga Investments B.V), Sathgen Therapeutics LLC (Subsidiary of Godavari Biorefineries Inc.)
Auditor Information: Verma Mehta & Associates, Chartered Accountants
Company Secretary: Swarna Gunware
Chairman & Managing Director: Samir Somaiya (DIN: 00295458)